CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,033 | -74.4% | 11,329 | -56.9% | 0.00% | – |
| Q2 2023 | $74,432 | +1.2% | 26,301 | +75.6% | 0.00% | – |
| Q1 2023 | $73,537 | -55.3% | 14,977 | -2.1% | 0.00% | – |
| Q4 2022 | $164,354 | +14.9% | 15,303 | +0.1% | 0.00% | – |
| Q3 2022 | $143,000 | +2.9% | 15,288 | +0.8% | 0.00% | – |
| Q2 2022 | $139,000 | -46.7% | 15,162 | -29.4% | 0.00% | – |
| Q1 2022 | $261,000 | -96.5% | 21,490 | -96.2% | 0.00% | -100.0% |
| Q1 2020 | $7,435,000 | -18.0% | 562,800 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $9,067,000 | -13.7% | 562,800 | -2.1% | 0.01% | -16.7% |
| Q3 2019 | $10,504,000 | +8.4% | 574,600 | +27.5% | 0.01% | +20.0% |
| Q2 2019 | $9,686,000 | +9.6% | 450,500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $8,839,000 | +50.9% | 450,500 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $5,857,000 | -45.7% | 450,500 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $10,789,000 | +25.1% | 450,500 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $8,627,000 | +54.7% | 450,500 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $5,577,000 | +1.1% | 450,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,514,000 | -7.3% | 450,500 | +3.7% | 0.00% | 0.0% |
| Q3 2017 | $5,948,000 | -11.1% | 434,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $6,687,000 | -38.6% | 434,500 | -26.6% | 0.00% | -50.0% |
| Q1 2017 | $10,892,000 | +98.0% | 592,300 | 0.0% | 0.01% | +100.0% |
| Q4 2016 | $5,502,000 | +7.8% | 592,300 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $5,105,000 | +73.6% | 611,400 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,941,000 | -22.7% | 611,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,803,000 | -63.1% | 611,400 | 0.0% | 0.00% | -60.0% |
| Q4 2015 | $10,308,000 | +18.0% | 611,400 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $8,737,000 | +17.6% | 611,400 | 0.0% | 0.00% | +33.3% |
| Q2 2015 | $7,429,000 | +20.9% | 611,400 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,145,000 | +0.8% | 611,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $6,096,000 | +18.8% | 611,400 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $5,130,000 | -54.9% | 611,400 | -8.6% | 0.00% | -60.0% |
| Q2 2014 | $11,380,000 | -5.6% | 668,600 | +3.2% | 0.01% | -16.7% |
| Q1 2014 | $12,061,000 | – | 648,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |